EP1820852A4 - Serum humain pour culture cellulaire - Google Patents

Serum humain pour culture cellulaire

Info

Publication number
EP1820852A4
EP1820852A4 EP05805407A EP05805407A EP1820852A4 EP 1820852 A4 EP1820852 A4 EP 1820852A4 EP 05805407 A EP05805407 A EP 05805407A EP 05805407 A EP05805407 A EP 05805407A EP 1820852 A4 EP1820852 A4 EP 1820852A4
Authority
EP
European Patent Office
Prior art keywords
cell culture
human serum
serum
human
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05805407A
Other languages
German (de)
English (en)
Other versions
EP1820852A1 (fr
Inventor
Koji Suzuki
Seishin Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JMS Co Ltd
Original Assignee
JMS Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JMS Co Ltd filed Critical JMS Co Ltd
Publication of EP1820852A1 publication Critical patent/EP1820852A1/fr
Publication of EP1820852A4 publication Critical patent/EP1820852A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP05805407A 2004-11-19 2005-11-02 Serum humain pour culture cellulaire Withdrawn EP1820852A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004335344 2004-11-19
PCT/JP2005/020238 WO2006054448A1 (fr) 2004-11-19 2005-11-02 Sérum humain pour culture cellulaire

Publications (2)

Publication Number Publication Date
EP1820852A1 EP1820852A1 (fr) 2007-08-22
EP1820852A4 true EP1820852A4 (fr) 2007-11-14

Family

ID=36406993

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05805407A Withdrawn EP1820852A4 (fr) 2004-11-19 2005-11-02 Serum humain pour culture cellulaire

Country Status (7)

Country Link
US (2) US20090075355A1 (fr)
EP (1) EP1820852A4 (fr)
JP (1) JPWO2006054448A1 (fr)
KR (2) KR101016504B1 (fr)
CN (1) CN101061218A (fr)
CA (1) CA2587885C (fr)
WO (1) WO2006054448A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008109866A (ja) * 2006-10-30 2008-05-15 Jms Co Ltd 培地添加剤、この培地添加剤を含む培地、及びこの培地を用いた細胞の培養方法
JP5577569B2 (ja) * 2007-03-07 2014-08-27 株式会社ジェイ・エム・エス 血清調製方法
PT2194121T (pt) 2007-09-11 2016-12-05 Univ Sapporo Medical Método de proliferação celular e agente farmacêutico para reparação e regeneração de tecidos
ES2360782B1 (es) 2009-07-28 2012-03-12 Grifols, S.A. Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.
KR20130096731A (ko) * 2010-09-08 2013-08-30 할로자임, 아이엔씨 조건부 활성 치료적 단백질을 평가，확인 또는 진화시키는 방법
JP6452271B2 (ja) * 2012-12-13 2019-01-16 株式会社ジェイ・エム・エス 血清の調製方法
US10172347B2 (en) 2014-07-08 2019-01-08 Jeong Chan Ra Composition for improving stability of stem cells
CN105769909A (zh) * 2016-05-13 2016-07-20 云南舜喜再生医学工程有限公司 一种直接获得富含细胞因子血清的采血器及方法
CN111728867B (zh) * 2020-08-01 2024-06-25 河南方舟医疗器械有限公司 一种血清无菌制备分装输出系统及方法
CN114146096B (zh) * 2021-11-25 2024-04-02 成都清科生物科技有限公司 一种富含细胞因子的条件血清的制备方法及应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027996A1 (fr) * 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Milieu exempt de serum pour cellules de type chondrocyte
EP1464697A1 (fr) * 2002-01-09 2004-10-06 Alberto Gorrochategui Barrueta Composition et procede de creation, de regeneration et de reparation de tissus a l'aide d'un implant biologique porteur de cellules et enrichi de concentre de plaquettes et de supplements
WO2004103440A1 (fr) * 2003-05-21 2004-12-02 Jms Co., Ltd. Recipient pour production de serum et methode de medecine regeneratrice utilisant ledit recipient

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189382A (en) * 1974-11-07 1980-02-19 Sherwood Medical Industries Inc. Blood coagulation and separation
JPS57197471A (en) 1981-05-29 1982-12-03 Sekisui Chem Co Ltd Blood coagulation accelerant
EP0168755B1 (fr) * 1984-07-16 1991-04-17 Sumitomo Bakelite Company Limited Récipient et méthode pour la conservation de sang
US4807676A (en) * 1985-02-26 1989-02-28 Baxter International Inc. Fluid transfer workstation
JPH01230521A (ja) * 1989-01-13 1989-09-14 Nippon Sekijiyuujishiya 血液成分の分離方法
JPH0483165A (ja) * 1990-07-26 1992-03-17 Asahi Fiber Glass Co Ltd 体液の処理方法
JPH0483167A (ja) * 1990-07-26 1992-03-17 Asahi Fiber Glass Co Ltd 体液の処理方法
JPH06227993A (ja) 1993-01-29 1994-08-16 Terumo Corp 血液製剤調製装置
CA2130893A1 (fr) * 1993-09-17 1995-03-18 Bayer Corporation Methode et systeme de prelevement, de traitement et d'entreposage de constituants sanguins
JPH07330620A (ja) 1994-06-07 1995-12-19 Nippon Seiyaku Kk 血漿蛋白質の連続分画方法および装置
US6478808B2 (en) * 1997-12-17 2002-11-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
JP2000000228A (ja) * 1998-06-12 2000-01-07 Terumo Corp 採血管
JP2001275662A (ja) 2000-04-03 2001-10-09 Nobuhiko Emi ヒト血清及びその製造方法
JP4110285B2 (ja) * 2003-03-07 2008-07-02 愛知県 血清の製造方法
JP4682591B2 (ja) * 2003-05-21 2011-05-11 株式会社ジェイ・エム・エス 血液成分分離収容装置及び血清調製方法
JP4501551B2 (ja) 2004-06-23 2010-07-14 富士ゼロックス株式会社 ３次元形状測定装置および方法
JP2006104106A (ja) * 2004-10-04 2006-04-20 Olympus Corp 血清の分離方法および細胞の培養方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027996A1 (fr) * 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Milieu exempt de serum pour cellules de type chondrocyte
EP1464697A1 (fr) * 2002-01-09 2004-10-06 Alberto Gorrochategui Barrueta Composition et procede de creation, de regeneration et de reparation de tissus a l'aide d'un implant biologique porteur de cellules et enrichi de concentre de plaquettes et de supplements
WO2004103440A1 (fr) * 2003-05-21 2004-12-02 Jms Co., Ltd. Recipient pour production de serum et methode de medecine regeneratrice utilisant ledit recipient
EP1625861A1 (fr) * 2003-05-21 2006-02-15 JMS Co. Ltd. Recipient pour production de serum et methode de medecine regeneratrice utilisant ledit recipient

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MCALINDEN M G ET AL: "COMPARISON OF CANCELLOUS BONE-DERIVED CELL PROLIFERATION IN AUTOLOGOUS HUMAN AND FETAL BOVINE SERUM", CELL TRANSPLANTATION, ELSEVIER SCIENCE, US, vol. 9, no. 4, July 2000 (2000-07-01), pages 445 - 451, XP008035756, ISSN: 0963-6897 *
MIZUNO ET AL: "Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures", CELL BIOLOGY INTERNATIONAL, ACADEMIC PRESS, GB, vol. 30, no. 6, June 2006 (2006-06-01), pages 521 - 524, XP005473441, ISSN: 1065-6995 *
See also references of WO2006054448A1 *
STUTE N ET AL: "Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, vol. 32, no. 12, December 2004 (2004-12-01), pages 1212 - 1225, XP004674871, ISSN: 0301-472X *

Also Published As

Publication number Publication date
CA2587885A1 (fr) 2006-05-26
US20090075355A1 (en) 2009-03-19
US8679838B2 (en) 2014-03-25
EP1820852A1 (fr) 2007-08-22
WO2006054448A1 (fr) 2006-05-26
JPWO2006054448A1 (ja) 2008-05-29
US20100167402A1 (en) 2010-07-01
KR20070060148A (ko) 2007-06-12
CA2587885C (fr) 2013-05-21
CN101061218A (zh) 2007-10-24
KR101016504B1 (ko) 2011-02-24
KR20100024522A (ko) 2010-03-05

Similar Documents

Publication Publication Date Title
EP1815244A4 (fr) Dispositif de culture de cellules
GB2432835B (en) Culturing human embryonic stem cells
GB2411178A8 (en) Apparatus for culturing cells
EP1729798A4 (fr) Therapie utilisant des lymphocytes t specifiques aux antigenes
EP1820852A4 (fr) Serum humain pour culture cellulaire
SI2573166T1 (sl) Metode za pripravo T-celic za celično terapijo
EP1882736A4 (fr) Recipient de culture cellulaire
EP1947990A4 (fr) Dispositif de culture cellulaire microfluidique
IL179311A0 (en) Membrane bioreactor
IL176641A0 (en) Novel culture systems for ex vivo development
EP1789528A4 (fr) Bioreacteur pour la culture de cellules sous perfusion
GB0525579D0 (en) Cell culture vessel
IL184262A (en) A method for culturing cells in culture
EP1734110A4 (fr) Dispositif de culture
GB0410118D0 (en) Novel bioreactor
GB0517382D0 (en) Cell culture
GB2404665B (en) Cell culture
EP1967582A4 (fr) Materiau pour une culture de cellule
EP1820847A4 (fr) Composition pour stockage de cellules par congelation
ZA200703293B (en) Cell bandage
HK1106558A1 (en) Electrochemical cell
ZA200506732B (en) Cell culture
GB0420881D0 (en) Bioreactor
GB0426182D0 (en) Photoporation of cells
ZA200704058B (en) Methods for producing mammalian cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070514

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20071012

17Q First examination report despatched

Effective date: 20071204

R17C First examination report despatched (corrected)

Effective date: 20071213

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090731